Maria
Vieito Amor
The Bristol-Myers Squibb Children's Hospital
Nuevo Brunswick, Estados UnidosPublications in collaboration with researchers from The Bristol-Myers Squibb Children's Hospital (3)
2023
-
BET inhibitor trotabresib in heavily pretreated patients with solid tumors and diffuse large B-cell lymphomas
Nature communications, Vol. 14, Núm. 1, pp. 1359
2022
-
Trotabresib (CC-90010) in combination with adjuvant temozolomide or concomitant temozolomide plus radiotherapy in patients with newly diagnosed glioblastoma
Neuro-Oncology Advances, Vol. 4, Núm. 1
2020
-
Phase I study of CC-90010, a reversible, oral BET inhibitor in patients with advanced solid tumors and relapsed/refractory non-Hodgkin's lymphoma
Annals of Oncology, Vol. 31, Núm. 6, pp. 780-788